The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2020

Filed:

Aug. 31, 2018
Applicant:

Santarus, Inc., Bridgewater, NJ (US);

Inventors:

Craig Michael Bowe, Encinatas, CA (US);

John Christopher Carter, Keswick, CA;

Dana Elaine Moseson, West Lafayette, IN (US);

Stephen Paul Levine, Norristown, PA (US);

Assignee:

Santarus, Inc., Bridgewater, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/58 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 31/606 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2077 (2013.01); A61K 9/2018 (2013.01); A61K 9/2866 (2013.01); A61K 9/2886 (2013.01); A61K 9/4808 (2013.01); A61K 31/58 (2013.01); A61K 31/606 (2013.01); A61K 9/2846 (2013.01);
Abstract

Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-released solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention related to a methods of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowl disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.


Find Patent Forward Citations

Loading…